Coincidentally, it’s also the 100-day mark for the return of The Buzz, give or take; we can’t count past 19 since the Lawnmower Incident. To our credit, we’re pretty sure we can’t be blamed for a ...

Mark Bradford was born in Los Angeles, California, in 1961. He received a BFA (1995) and MFA (1997) from the California Institute of the Arts in Valencia. Bradford transforms materials scavenged from ...

It just so happens Georgia guard Tate Ratledge got a giant Lion tattoo on his right forearm about a year ago. "That kind of came full circle and I didn't process it until right now," Ratledge said in ...

Four-time world champion Mark Selby was dumped out of the competition last night, with Lucas Brecel putting on a show to reach the second round. The morning session returns today, with Mark Allen ...

PORTLAND, Ore. — Ten players from the University of Oregon were selected in the 2025 NFL Draft, setting a new mark for the school, exceeding the program-record eight selected last year.

One hundred and ten years after Australian and New Zealand soldiers landed on the Turkish coastline at Gallipoli, thousands of people have come together to mark Anzac Day. The 25th of April 1915 ...

Liberal Leader Mark Carney is in the Sault today to deliver remarks and speak with the media. Watch a live feed from his visit on CPAC, with coverage starting around 9:30 a.m. SooToday will have ...

Mark Allen fired in the 15th 147 maximum break in Crucible history during his World Championship clash with Chris Wakelin, but still suffered a 13-6 defeat. The Northern Irishman was trailing an ...

Bangalore Gold Price Today: The price of gold in Bangalore fell for the second consecutive day after touching the record high mark of Rs 1 lakh. The second consecutive fall in gold rates today in ...

Vice President of Marketing at Mark Anthony Brands Inc., which owns White Claw, said in a statement. “ClawTails is an entirely new way to enjoy every social gathering with a line of drinks that ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. The candidate fell short in a phase 2 psoriasis trial, prompting the French drugmaker to pull back from plans to ...